https://www.selleckchem.com/pr....oducts/nocodazole.ht
The crosswalk had modest prediction accuracy (MAE = 0.092, RMSE = 0.114, AIC = -2708 and BIC = -2595.6), which are comparable to prediction accuracies of other SF-6D crosswalks in the literature. About 24% and 52% of predictions fell within ± 5% and ± 10% of observed SF-6D, respectively. The observed mean disutility associated with acquiring clinically significant PCRA is 0.168 (standard deviation = 0.179). This study provides a crosswalk that converts MAX-PC scores to SF-6D utilities for economic evaluation of clinically significant
Me gusta
Comentario
Compartir
